[Use of fibrinolysin (plasmin) in thromboembolic diseases]. 1958

I MACIAS CASTRO

UI MeSH Term Description Entries
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms

Related Publications

I MACIAS CASTRO
December 1962, New York state journal of medicine,
I MACIAS CASTRO
June 1961, Journal of the Indian Medical Association,
I MACIAS CASTRO
October 1961, Die Medizinische Welt,
I MACIAS CASTRO
May 1961, Angiology,
I MACIAS CASTRO
January 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
I MACIAS CASTRO
July 1960, Vox sanguinis,
I MACIAS CASTRO
November 1958, Journal of the American Medical Association,
I MACIAS CASTRO
February 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!